Clinical Trial: A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes

U.S., Aug. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07124208) titled 'A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes' on Aug. 04.

Brief Summary: Study Objective The purpose of this clinical study is to evaluate if biophoton therapy, delivered by Tesla BioHealing(R) Biophoton Generators (Biophotonizer), can treat diabetes.

Study Design This is a randomized, double-blind, placebo-controlled intervention clinical study to assess the effectiveness of biophoton therapy in treating diabetes. Approximately 46 volunteers will participate in the study.

Study Randomization The biostatistician will prepare a randomization schedule i...